ANGELA COBB: Open Payments
NPI 1487960373 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$977 in 23 payments from 10 companies in 2025. Trend: 2023 $1,317 · 2024 $1,041 · 2025 $977
Food & beverage: $932Education: $45
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $260 |
| Novo Nordisk Inc | 9 | $209 |
| Lilly USA, LLC | 4 | $157 |
| Paratek Pharmaceuticals, Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $71 |
| Stryker Corporation | 1 | $50 |
| PFIZER INC. | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 1 | $36 |
| Boston Scientific Corporation | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $14 |
Products named: REPATHA, Wegovy, NUZYRA, ZEPBOUND, Auvelity, PAXLOVID, VOQUEZNA, General - Therapies.
Industry payments across AL — which companies pay providers there.
